{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:00:36Z","timestamp":1771023636109,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vaccine.2019.07.097","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T08:13:16Z","timestamp":1565683996000},"page":"5698-5707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis"],"prefix":"10.1016","volume":"37","author":[{"given":"Maarten","family":"van Wijhe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter T.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman J.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"van Vliet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacco","family":"Wallinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten J.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.07.097_b0005","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.vaccine.2010.02.021","article-title":"Criteria for inclusion of vaccinations in public programmes","volume":"28","author":"Houweling","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.097_b0010","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1016\/j.vaccine.2013.08.008","article-title":"The role of health economic analyses in vaccine decision making","volume":"31","author":"Black","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.097_b0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1377\/hlthaff.22.3.89","article-title":"It's the prices, stupid: why the United States is so different from other countries","volume":"22","author":"Anderson","year":"2003","journal-title":"Health Affair"},{"key":"10.1016\/j.vaccine.2019.07.097_b0020","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1086\/420748","article-title":"Financing immunizations in the United States","volume":"38","author":"Hinman","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.097_b0025","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4161\/hv.6.9.13496","article-title":"Price as a double-edged sword in the golden era of vaccines","volume":"6","author":"Davis","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2019.07.097_b0030","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(08)61257-X","article-title":"Health economics and prioritising health care","volume":"372","author":"Meltzer","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.07.097_b0035","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S1473-3099(16)00027-X","article-title":"Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysis","volume":"16","author":"van Wijhe","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.097_b0040","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1017\/S0950268818000481","article-title":"Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands","volume":"146","author":"van Wijhe","year":"2018","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.07.097_b0045","first-page":"1806","article-title":"De inentingen tegen diphtherie en de propaganda hiervoor","volume":"98","author":"Hoogendoorn","year":"1954","journal-title":"Ned Tijdsch Geneeskd"},{"key":"10.1016\/j.vaccine.2019.07.097_b0050","first-page":"13","article-title":"Het ontstaan van het Rijksvaccinatieprogramma. Deel 1: De vroege jaren van vaccinatie in Nederland 1823\u20131949","volume":"15","author":"Vos","year":"2004","journal-title":"Infect Bull"},{"key":"10.1016\/j.vaccine.2019.07.097_b0055","first-page":"49","article-title":"Het ontstaan van het Rijksvaccinatieprogramma. Deel 2: Aanloop en totstandkoming van het RVP: 1949\u20131963","volume":"15","author":"Vos","year":"2004","journal-title":"Infect Bull"},{"key":"10.1016\/j.vaccine.2019.07.097_b0060","unstructured":"van Lier EA, Geraedts JLE, Oomen PJ, et al. Vaccinatiegraad en jaarverslag Rijksvaccinatieprogramma Nederland 2017. 2018. RIVM report 2018-0008."},{"key":"10.1016\/j.vaccine.2019.07.097_b0065","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1586\/14760584.2013.824709","article-title":"The evolving history of influenza viruses and influenza vaccines","volume":"12","author":"Hannoun","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.07.097_b0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/bmj.303.6801.508","article-title":"Use of influenza vaccine in The Netherlands","volume":"303","author":"Meynaar","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.07.097_b0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/oxfordjournals.pubmed.a024478","article-title":"Increasing the coverage of vaccination against influenza by general practitioners","volume":"18","author":"Perenboom","year":"1996","journal-title":"J Public Health Med"},{"key":"10.1016\/j.vaccine.2019.07.097_b0080","first-page":"1779","article-title":"Influenza-vaccinatie: de baten worden nog steeds onderschat (in Dutch)","volume":"127","author":"Beyer","year":"1983","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.vaccine.2019.07.097_b0085","unstructured":"Davidse W, van Essen GA, Hutten JBF, et al. Influenzavaccinatie. Verslag van programmatische preventie in twee regio's (in Dutch). Leiden: TNO Preventie en Gezondheid, 1994. ISBN: 90-6743-340-3."},{"key":"10.1016\/j.vaccine.2019.07.097_b0090","first-page":"1968","article-title":"Influenzavaccinatie en de Postbus 51-campagne (in Dutch)","volume":"136","author":"Sprenger","year":"1992","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.07.097_b0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00019053-199916001-00005","article-title":"Economic evaluation of influenza vaccination. Assessment for The Netherlands","volume":"16","author":"Postma","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2019.07.097_b0100","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1016\/j.vaccine.2015.07.052","article-title":"Dutch influenza vaccination rate drops for fifth consecutive year","volume":"33","author":"Tacken","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.097_b0105","article-title":"Monitor Vaccinatiegraad Nationaal Programma Grieppreventie 2016 (in Dutch)","author":"Heins","year":"2017","journal-title":"Nivel"},{"key":"10.1016\/j.vaccine.2019.07.097_b0110","unstructured":"Statistics Netherlands (CBS). Healthcare; spending and finance since 1972 [Zorg; uitgaven en financiering vanaf 1972]. Den Haag\/Heerlen: Statistics Netherlands (CBS); 2017. https:\/\/opendata.cbs.nl\/statline\/#\/CBS\/nl\/dataset\/83075NED\/table?fromstatweb"},{"key":"10.1016\/j.vaccine.2019.07.097_b0115","unstructured":"Statistics Netherlands (CBS). Population; key figures [Bevolking; kerncijfers]. Den Haag\/Heerlen: Statistics Netherlands (CBS); 2017. https:\/\/opendata.cbs.nl\/statline\/#\/CBS\/nl\/dataset\/37296NED\/table?fromstatweb"},{"key":"10.1016\/j.vaccine.2019.07.097_b0120","unstructured":"Netherlands Bureau for Economic Policy Analysis (CPB). Lange tijdreeksen overheidsfinancien [in Dutch]. Netherlands Bureau for Economic Policy Analysis (CPB); 2017. https:\/\/www.cpb.nl\/cijfer\/lange-tijdreeksen-overheidsfinancien"},{"key":"10.1016\/j.vaccine.2019.07.097_b0125","unstructured":"[dataset] [25] Statistics Netherlands (CBS). Consumer prices, price index 1900 = 100 [Consumentenprijzen, prijsindex 1900 = 100]. Den Haag\/Heerlen: Statistics Netherlands (CBS); 2017. https:\/\/opendata.cbs.nl\/statline\/#\/CBS\/nl\/dataset\/71905ned\/table?fromstatweb"},{"key":"10.1016\/j.vaccine.2019.07.097_b0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1586\/14760584.3.4.433","article-title":"Cost-effectiveness studies of pneumococcal conjugate vaccines","volume":"3","author":"McIntosh","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.07.097_b0135","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.vaccine.2006.10.034","article-title":"Convincing or confusing?: Economic evaluations of childhood pneumococcal conjugate vaccination\u2013a review (2002\u20132006)","volume":"25","author":"Beutels","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.097_b0140","doi-asserted-by":"crossref","first-page":"c2509","DOI":"10.1136\/bmj.c2509","article-title":"Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines","volume":"340","author":"Rozenbaum","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.07.097_b0145","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.vaccine.2010.01.005","article-title":"Hak E, Postma MJ. Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar \u00ae)","volume":"28","author":"Rozenbaum","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.097_b0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jinf.2011.10.015","article-title":"Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands","volume":"64","author":"Strutton","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2019.07.097_b0155","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.vaccine.2015.01.081","article-title":"Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: A review of economic evaluations (2006\u20132014)","volume":"33","author":"Bin","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.097_b0160","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.vaccine.2015.12.066","article-title":"Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2\u20136 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands","volume":"34","author":"Wagenvoort","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.097_b0165","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/S0149-2918(03)80322-3","article-title":"Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands","volume":"25","author":"Bos","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.vaccine.2019.07.097_b0170","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1183\/13993003.00325-2015","article-title":"Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands","volume":"46","author":"Mangen","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2019.07.097_b0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/14760584.2017.1242419","article-title":"Evaluating the costs and benefits of pneumococcal vaccination in adults","volume":"16","author":"Porchia","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.07.097_b0180","series-title":"Vaccination of elderly against pneumococcus","author":"Health Council of the Netherlands","year":"2018"},{"key":"10.1016\/j.vaccine.2019.07.097_b0185","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1471-2458-7-252","article-title":"Towards a comprehensive estimate of national spending on prevention","volume":"7","author":"de Bekker-Grob","year":"2007","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2019.07.097_b0190","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1080\/21645515.2016.1155013","article-title":"How much money is spent on vaccines across Western European countries?","volume":"12","author":"Ethgen","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.07.097_b0195","first-page":"1","article-title":"Vaccination budget in Europe: an update","volume":"30","author":"Ethgen","year":"2018","journal-title":"Hum vaccin immunother"},{"key":"10.1016\/j.vaccine.2019.07.097_b0200","unstructured":"WHO. World Health Organization Global Health Expenditure database; 2017. https:\/\/apps.who.int\/nha\/database"},{"key":"10.1016\/j.vaccine.2019.07.097_b0205","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.vaccine.2004.06.019","article-title":"Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making","volume":"23","author":"Welte","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.097_b0210","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","article-title":"Group V-PDTW. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States","volume":"298","author":"Roush","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2019.07.097_b0215","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1056\/NEJMms1215400","article-title":"Contagious diseases in the United States from 1888 to the present","volume":"369","author":"van Panhuis","year":"2013","journal-title":"New EngJ Med"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2019.07.097_b0220","first-page":"49","article-title":"Vaccine-preventable diseases, immunizations, and MMWR\u20131961-2011","volume":"60","author":"Hinman","year":"2011","journal-title":"MMWR-Morbid Mortal W"},{"key":"10.1016\/j.vaccine.2019.07.097_b0225","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.vaccine.2003.10.027","article-title":"The societal value of universal childhood vaccination","volume":"22","author":"Chabot","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.097_b0230","doi-asserted-by":"crossref","first-page":"12282","DOI":"10.1073\/pnas.1413559111","article-title":"Vaccines: science, health, longevity, and wealth","volume":"111","author":"Rappuoli","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.07.097_b0235","doi-asserted-by":"crossref","first-page":"B29","DOI":"10.1016\/j.vaccine.2015.03.023","article-title":"Valuing vaccines: deficiencies and remedies","volume":"33","author":"Bloom","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.097_b0240","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12916-015-0446-9","article-title":"The broader economic impact of vaccination: reviewing and appraising the strength of evidence","volume":"13","author":"Jit","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2019.07.097_b0245","series-title":"Vaccination against rotavirus","author":"Health Council of the Netherlands","year":"2017"},{"key":"10.1016\/j.vaccine.2019.07.097_b0250","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1016\/j.vaccine.2014.10.008","article-title":"What is the responsibility of national government with respect to vaccination?","volume":"32","author":"Verweij","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:59Z","timestamp":1759401239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19310187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":50,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0264410X19310187"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.097","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}